Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

Microsoft Tries to Catch Up in AI With Healthcare Push, Harvard Deal

by Team Lumida
October 9, 2025
in AI
Reading Time: 3 mins read
A A
0
Microsoft’s AI Ambitions: A Costly Path Forward

FILE PHOTO: A Microsoft logo is seen in Los Angeles, California, U.S. June 14, 2016. REUTERS/Lucy Nicholson

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways

Powered by lumidawealth.com

  • Microsoft is developing its own AI chatbot capabilities to reduce reliance on OpenAI and establish its Copilot assistant as a consumer brand, focusing initially on healthcare.
  • A major update to Copilot, expected soon, will integrate licensed content from Harvard Medical School’s Harvard Health Publishing to provide credible, tailored healthcare information.
  • Microsoft aims for Copilot to offer medical advice closer to what users might receive from healthcare professionals, addressing concerns about chatbot accuracy in medical contexts.
  • The company is also developing tools to help users find healthcare providers based on needs and insurance coverage.
  • Microsoft AI chief Mustafa Suleyman has prioritized healthcare, expanding internal AI teams and developing AI tools that outperform doctors in disease diagnosis at lower costs.
  • Despite extending its partnership with OpenAI, Microsoft is investing heavily in building its own AI models and infrastructure to eventually replace some OpenAI workloads.

What happened?

Microsoft is accelerating efforts to build proprietary AI chatbot technology, with healthcare as a strategic focus area. The upcoming Copilot update will leverage Harvard’s trusted medical content to improve reliability and user trust. This move reflects Microsoft’s ambition to compete more independently in the AI space while maintaining a partnership with OpenAI.

Why it matters

Healthcare is a high-value, sensitive sector where accurate AI assistance can have significant impact, making it a key battleground for AI providers. Microsoft’s push into healthcare AI could differentiate its Copilot offering and expand its consumer and enterprise AI footprint. For investors, Microsoft’s AI strategy signals a long-term commitment to innovation and competition in a rapidly evolving market.

What’s next?

Monitor the rollout and user reception of the updated Copilot healthcare features. Watch Microsoft’s progress in developing homegrown AI models and reducing dependence on OpenAI. Track competitive moves by other AI players in healthcare and enterprise sectors. Investor focus should include Microsoft’s AI revenue growth, partnerships, and technological advancements.

Source
Previous Post

China Imposes New Controls Over Rare-Earth Exports

Next Post

Trump Calls for Jailing of Chicago Mayor and Illinois Governor

Recommended For You

OpenAI CEO Says U.S. Shouldn’t Bail Out AI Companies

by Team Lumida
23 hours ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways Powered by lumidawealth.com Sam Altman rejected calls for federal guarantees or bailouts for AI companies, saying OpenAI should succeed or fail on merit. His remarks followed CFO...

Read more

Some Tesla Shareholders Want It to Invest in xAI. The Board Isn’t So Sure.

by Team Lumida
23 hours ago
Some Tesla Shareholders Want It to Invest in xAI. The Board Isn’t So Sure.

Key Takeaways Powered by lumidawealth.com A nonbinding proposal asking Tesla to invest in Elon Musk’s xAI gained more votes for than against, though many shareholders abstained. The Tesla board...

Read more

CoreWeave CEO Plays Down Concerns About AI-Spending Bubble

by Team Lumida
2 days ago
CoreWeave CEO Plays Down Concerns About AI-Spending Bubble

Key Takeaways Powered by lumidawealth.com CoreWeave CEO Michael Intrator dismissed Wall Street fears of an AI infrastructure bubble, calling the trillions in investment “sustainable and essential for economic growth.”...

Read more

These AI Power Users Are Impressing Bosses and Leaving Co-Workers in the Dust

by Team Lumida
2 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Key Takeaways Powered by lumidawealth.com AI power users are outperforming peers by mastering practical applications of tools like ChatGPT and Gemini. Employers now openly acknowledge that AI proficiency can...

Read more

Amazon Sues Perplexity AI Over “Comet” Shopping Agent, Setting Stage for Legal Battle on AI Autonomy

by Team Lumida
3 days ago
Amazon’s $100 Billion Bet: AI Over Retail

Key Takeaways:Powered by lumidawealth.com Amazon filed a lawsuit against Perplexity AI to stop its browser agent Comet from buying products on Amazon’s marketplace. Amazon alleges computer fraud and breach...

Read more

Amazon Inks $38 Billion Deal With OpenAI for Nvidia Chips

by Team Lumida
4 days ago
Amazon’s $100 Billion Bet: AI Over Retail

Key Takeaways from the Amazon–OpenAI Partnership Powered by lumidawealth.com Deal Value: $38 billion, seven-year cloud infrastructure contract. Hardware Backbone: Nvidia GB200 and GB300 AI accelerators powering ChatGPT. Strategic Impact:...

Read more

AI Layoffs Arrive: Efficiency Mandate and Small Models Reshape White-Collar Work

by Team Lumida
5 days ago
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Key Takeaways Powered by lumidawealth.com Big Tech layoffs (e.g., Amazon’s 14,000) signal a pivot to leaner orgs as AI tools replace routine coding and ops work. Management frames cuts...

Read more

Big Tech’s AI Capex Surges to $400B in 2025 and Rising in 2026

by Team Lumida
1 week ago
Big Tech’s AI Capex Surges to $400B in 2025 and Rising in 2026

Key Takeaways Powered by lumidawealth.com Alphabet, Meta, Microsoft, and Amazon plan ~$400B AI spend in 2025; all guide higher for 2026. Capacity remains short; Microsoft says demand still outpaces...

Read more

OpenAI Weighs $1 Trillion IPO Target Amid Massive AI Buildout

by Team Lumida
1 week ago
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

Key Takeaways Powered by lumidawealth.com Reuters reports OpenAI may pursue a 2026 IPO targeting a ~$1T valuation; company says an IPO is “not our focus.” Recent corporate restructuring makes...

Read more

Nvidia Becomes First $5 Trillion Company as AI Supercycle Accelerates

by Team Lumida
1 week ago
Nvidia’s Stock: Is It Too Good to Be True Now?

Key Takeaways Powered by lumidawealth.com Market cap hits ~$5.03T with shares at $207.16; first company to cross $5T. AI demand drives scale: ~6M Blackwell GPUs shipped; ~14M on order....

Read more
Next Post
Trump Tariffs Leave Key Questions on China Supply Chain Rules Unanswered

Trump Calls for Jailing of Chicago Mayor and Illinois Governor

woman in white dress shirt and black pants standing near brown wooden shelf

Trump Excludes Generics From Big Pharma Tariff Plan

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Credit Card Chaos: Why Your Balance Costs More

Credit Card Chaos: Why Your Balance Costs More

October 8, 2024
Eaton Corporation Q2 2024 Earnings Highlights : Strong Quarter, $1Bn in CAPEX

Eaton Corporation Q2 2024 Earnings Highlights : Strong Quarter, $1Bn in CAPEX

August 2, 2024
UnitedHealth Faces Critical Earnings Report Amid Leadership Crisis and Regulatory Pressure

UnitedHealth Faces Critical Earnings Report Amid Leadership Crisis and Regulatory Pressure

January 16, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018